Enclomiphene and 'MK-344': separating gym hype from real data

What did @.bamnesia actually say?

Honestly, not much. The transcript is essentially unintelligible audio, likely a corrupted or auto-captioned file. The real substance lives in the caption, where the creator writes that enclomiphene ('enclo') is a 'test booster' and that 'compound 344' is a 'myostatin inhibitor,' and that both lead to gains. That's the claim we're fact-checking here, because the caption is what 2,300 viewers are reading.

The framing is casual and the creator seems self-aware, noting they're 'not a larp,' meaning they believe their own results. That kind of anecdote-forward content is exactly where gym communities pick up half-true information and run with it.

Does the science back this up?

On enclomiphene, yes, partially. On 'compound 344' as a myostatin inhibitor that builds muscle in humans, the evidence is thin to nonexistent at this point.

Enclomiphene is a selective estrogen receptor modulator (SERM), specifically the trans-isomer of clomiphene. It works by blocking estrogen receptors in the hypothalamus, which tricks the pituitary into releasing more LH and FSH, which then signals the testes to produce more testosterone. That mechanism is well-established. A 2013 trial by Kim et al. in BJU International showed enclomiphene restored testosterone levels in hypogonadal men while preserving sperm production, which is genuinely different from exogenous testosterone. Calling it a 'test booster' is a loose but defensible description.

'Compound 344' likely refers to a research chemical sometimes called YK11 or a related myostatin-pathway compound. Myostatin is a protein that limits muscle growth. Blocking it sounds like a bodybuilder's dream. In mice, myostatin knockout produces dramatically larger muscles (Lee, 2004, PNAS). In humans, selective inhibition via small molecules has not produced reliable, safe, replicated results. There are no completed Phase III trials on any oral myostatin inhibitor showing meaningful lean mass gains in healthy adults.

What did they get wrong (or right)?

The enclomiphene characterization is mostly right. Calling it a 'test booster' undersells the clinical specificity, but it's not wrong. It does raise endogenous testosterone through a real hormonal mechanism, not through caffeine or tribulus-style noise.

The myostatin inhibitor claim deserves more scrutiny. The creator states compound 344 'is a myostatin inhibitor' as settled fact. That's the problem.

• Most 'myostatin inhibitors' circulating in the research chemical market have limited or no published human pharmacokinetic data.
• YK11, one common candidate, is often classified as a SARM with partial myostatin-related activity. A 2022 review by Narayanan et al. in Steroids noted that SARMs including YK11 lack long-term safety data and have not cleared FDA approval for any indication.
• Attributing gains to a specific mechanism when you're also doing resistance training makes it impossible to isolate causality. The 'gains' could simply be the training.

The creator gets credit for transparency about what each compound supposedly does. That's more than most gym TikTok offers.

What should you actually know?

If you're considering enclomiphene, it is a prescription medication in most jurisdictions. It has a real mechanism, real clinical data, and real risks including mood changes, visual disturbances, and hormonal disruption if used without monitoring. A baseline hormone panel before and during use is standard clinical practice, not optional.

As for myostatin inhibitors marketed as research chemicals or peptides, the regulatory status matters here. The FDA has not approved any oral small-molecule myostatin inhibitor for human use. Compounds sold in this category exist in a legal and safety gray zone. 'Research chemical' is not a safety designation, it means not approved for human consumption. The absence of reported side effects in a TikTok comment section is not a clinical safety profile.

Stacking a SERM with an unapproved myostatin-pathway compound introduces hormonal and cardiovascular variables that no gym influencer can adequately assess. If you're interested in optimizing testosterone or recovery, a telehealth provider can evaluate whether evidence-based options are appropriate for your specific labs and history.

The bottom line on these compounds

Enclomiphene has real science behind it. Compound 344 as a muscle-building myostatin inhibitor in humans does not, at least not yet. The creator's personal gains are real to them, but anecdote is not mechanism, and mechanism is not proven human efficacy. These are not the same thing.